Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Las Vegas, NV
SEC filing record 1 source field available
Fiscal year end
30 April
PharmaCyte Biotech, Inc. has filed 469 SEC EDGAR filings since 20 Aug 2001

SEC filing history

Showing 176-200 of 389 matching filings.

Per page
25
Current page
8
D File 021-411887

D filing

Filing date
01 Sep 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
31 Aug 2021
Reporting date
10 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
31 Aug 2021
Reporting date
10 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
31 Aug 2021
Reporting date
10 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91495

SABBY 13G PMCB 8.30.21

Filing date
30 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91495

SCHEDULE 13G

Filing date
30 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-255044

PROSPECTUS SUPPLEMENT

Filing date
23 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40699

CURRENT REPORT

Filing date
23 Aug 2021
Reporting date
19 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
20 Aug 2021
Reporting date
10 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
20 Aug 2021
Reporting date
10 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
20 Aug 2021
Reporting date
10 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3MEF File 333-258921

FORM S-3 MEF

Filing date
19 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40699

FORM 8-K

Filing date
12 Aug 2021
Reporting date
09 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-40699

8A CERT

Filing date
10 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-255044

PROSPECTUS SUPPLEMENT

Filing date
10 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40699

CURRENT REPORT

Filing date
02 Aug 2021
Reporting date
02 Aug 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-255044

PROSPECTUS SUPPLEMENT

Filing date
02 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-40699

REGISTRATION OF CERTAIN CLASSES OF SECURITIES

Filing date
02 Aug 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 333-68008

NOTICE OF LATE FILING

Filing date
29 Jul 2021
Reporting date
30 Apr 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
13 Jul 2021
Reporting date
09 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
06 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
22 Jun 2021
Reporting date
18 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

CURRENT REPORT

Filing date
15 Jun 2021
Reporting date
14 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 333-68008

FORM 8-K

Filing date
04 Jun 2021
Reporting date
04 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .